Results 221 to 230 of about 140,854 (338)

Antibiotic resistance genes detected in lichens: insights from Cladonia stellaris. [PDF]

open access: yesAnn Bot
Alonso-García M   +5 more
europepmc   +1 more source

Lichen Nitidus [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1949
openaire   +3 more sources

Temporal and spatial variation in the composition of the lichen Hypogymnia physodes from the Niepołomice Forest (Poland). [PDF]

open access: yesSci Rep
Kościelniak R   +7 more
europepmc   +1 more source

Leukemia cutis as the first manifestation of acute myeloid leukemia

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Florian Winkler   +5 more
wiley   +1 more source

European forest carbon and biodiversity policies have a limited win-win potential. [PDF]

open access: yesNat Commun
Balducci L   +48 more
europepmc   +1 more source

Global consensus on the management of melanin hyperpigmentation disorders

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
A global Delphi consensus of 10 dermatology experts established evidence‐based recommendations for melanin hyperpigmentation disorders, providing unified classification, photoprotection guidance and treatment algorithms. This framework harmonizes terminology and supports individualized management across diverse skin types and health systems.
Thierry Passeron   +9 more
wiley   +1 more source

Aggressive squamous cell carcinomas arising from mucosal lichen planus: A report of three cases

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Neda Cramer   +5 more
wiley   +1 more source

Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In this interim analysis of the OLYMPIA long‐term extension trial, nemolizumab exhibited sustained efficacy and was well tolerated through 100 weeks, with most adverse events being mild/moderate. Patients showed clinically meaningful improvements in core signs and symptoms.
Franz J. Legat   +22 more
wiley   +1 more source

Home - About - Disclaimer - Privacy